This week, we’re joined by Valentino Parravicini, Chief Scientific Officer at Oxford Cannabinoid Technologies – British pharmaceutical company developing a portfolio of next-generation prescription cannabinoid medicines.
In this episode, we explore the potential use of cannabis-based medicines as a replacement for prescription opioids, their safety profile, and their use cases as analgesics.
